ADCC |
Antibody-Dependent Cell-Mediated Cytotoxicity |
AML |
Acute Myeloid Leukemia |
BTK |
Bruton Tyrosine Kinase |
CDK |
Cycle-dependent Kinase |
CLL |
Chronic Lymphatic Leukemia |
CRC |
Colorectal Cancer |
DC |
Dendritic Cells |
DDR |
DNA Damage Repair |
DNMT |
DNA Methyltransferase |
DTC |
Differentiated Thyroid Cancer |
HCC |
Hepatocellular Carcinoma |
HDAC |
Histone Deacetylases |
HNSCC |
Head and Neck Squamous Cell Carcinoma |
ICI |
Immune Checkpoint Inhibitor |
MCL |
Mantel Cell Lymphoma |
MDSC |
Myeloid Derived Suppressor Cells |
NK |
Nature Killer Cells |
NSCLC |
Non-small Cell Lung Cancer |
ORR |
Objective Response Rate |
OS |
Overall Survival |
PDAC |
Pancreatic Ductal Adenocarcinoma |
PFS |
Progression-free Survival |
PTC |
Papillary Thyroid Carcinoma |
RCC |
Renal Cell Carcinoma |
TAM |
Tumor-associated Macrophages |
TGF-β |
transforming growth factor-β |
TIB |
Tumor-infiltrating B Cells |
TIME |
Tumor Immune Microenvironment |
TKI |
Tyrosine Kinase Inhibitor |
TNBC |
Triple-negative Breast Cancer |